Many natural lectins have been reported to have antiviral activity. As some of these have
been put forward as potential development candidates for preventing or treating viral …

Virus entry into a susceptible host cell is the first step in the formation of all viral diseases.
Controlling viral infections by disrupting viral entry is advantageous for antibody-mediated …

Griffithsin (GRFT), an algae-derived lectin, is one of the most potent viral entry inhibitors
discovered to date. It is currently being developed as a microbicide with broad-spectrum …

The emergence of the Coronavirus Disease 2019 (COVID-19) caused by the SARS-CoV-2
virus has led to an unprecedented pandemic, which demands urgent development of …

Hepatitis C virus (HCV)-infected patients undergoing liver transplantation universally
experience rapid reinfection of their new liver graft. Current treatment protocols do not …

Lectins including flowering plant lectins, algal lectins, cyanobacterial lectins, actinomycete
lectin, worm lectins, and the nonpeptidic lectin mimics pradimicins and benanomicins …

Hepatitis C virus (HCV) infection is a significant public health problem with over 170,000,000
chronic carriers and infection rates increasing worldwide. Chronic HCV infection is one of …

Only a mere fraction of the huge variety of human pathogenic viruses can be targeted by the
currently available spectrum of antiviral drugs. The severe acute respiratory syndrome …

Griffithsin (GRFT) is a red-alga-derived lectin that binds the terminal mannose residues of N-
linked glycans found on the surface of human immunodeficiency virus type 1 (HIV-1), HIV-2 …

Lectins are unique proteins or glycoproteins of non-immune origin that bind specifically to
carbohydrates. They recognise and interact reversibly to either free carbohydrates or …